Vibrating Capsule for the Treatment of Chronic Idiopathic Constipation (CIC) and Constipation Predominant Irritable Bowel Syndrome (C-IBS) - Safety and Efficacy

被引：0

|

作者：

Ron, Yishai

Safadi, Rifaat

Dickman, Ram

Halpern, Zamir

机构：

来源：

GASTROENTEROLOGY | 2014年 / 146卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Sa2023

引用

收藏

页码：S357 / S357

页数：1

相关论文

共 50 条

[1] Efficacy and Safety of Plecanatide in Treatment of Irritable Bowel Syndrome With Constipation and Chronic Idiopathic Constipation
Ahmed, Shahzaib
Ahmad, Eeman
Akram, Umar
Al-bustami, Iyad
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S512 - S513
[2] Treatment Expectations and Drivers of Treatment Satisfaction Among Chronic Idiopathic Constipation (CIC) and Irritable Bowel Syndrome With Constipation (IBS-C) Patients
Arbuckle, Rob
Witherspoon, Brooke
Carson, Robyn
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S645 - S645
[3] Prucalopride accelerates small bowel and colonic transit in patients with chronic functional constipation (FC) or constipation-predominant irritable bowel syndrome (C-IBS).
Camilleri, M
McKinzie, S
Burton, D
Thomforde, GM
Zinsmeister, AR
Bouras, EP
GASTROENTEROLOGY, 2000, 118 (04) : A845 - A845
[4] Efficacy and Tolerability of Linaclotide and Plecanatide in Treating Irritable Bowel Syndrome With Constipation (IBS-C) and Chronic Idiopathic Constipation (CIC): A Meta-Analysis
Shah, Eric D.
Pimentel, Mark
Kim, Hyungjin
Schoenfeld, Philip
GASTROENTEROLOGY, 2016, 150 (04) : S739 - S739
[5] Efficacy and tolerability of linaclotide and plecanatide in treating Irritable Bowel Syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC): A meta-analysis
Shah, E.
Pimentel, M.
Kim, H.
Schoenfeld, P.
NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 101 - 101
[6] Decreased post-prandial 5 HT in constipation predominant irritable bowel syndrome (C-IBS)
Dunlop, SP
Coleman, NS
Blackshaw, PE
Perkins, AC
Singh, G
Marsden, CA
Spiller, RC
GUT, 2003, 52 : A16 - A16
[7] UNDIAGNOSED IRRITABLE BOWEL SYNDROME WITH CONSTIPATION (IBS-C) AND CHRONIC IDIOPATHIC CONSTIPATION (CIC): MORE COMMON THAN WE THOUGHT?
Lacy, Brian E.
Xu, Qingqing
Taylor, Douglas C.
Morlock, Amy
Morlock, Robert
Rooker, Ceciel
GASTROENTEROLOGY, 2022, 162 (07) : S691 - S691
[8] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
Maria I. Vazquez-Roque
Ernest P. Bouras
Advances in Therapy, 2013, 30 : 203 - 211
[9] Renzapride accelerates colonic transit and improves bowel function in constipation-predominant irritable bowel syndrome (C-IBS)
Camilleri, M
McKinzie, S
Fox, J
Foxx-Orenstein, A
Burton, D
Thomforde, G
Baxter, K
Zinsmeister, A
GASTROENTEROLOGY, 2004, 126 (04) : A642 - A642
[10] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
Vazquez-Roque, Maria I.
Bouras, Ernest P.
ADVANCES IN THERAPY, 2013, 30 (03) : 203 - 211

← 1 2 3 4 5 →